Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET-Reference-Cited by-同舟云学术

Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET

Published:2011-11-07 Issue:12 Volume:52 Page:1871-1877
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kahraman Deniz,Scheffler Matthias,Zander Thomas,Nogova Lucia,Lammertsma Adriaan A.,Boellaard Ronald,Neumaier Bernd,Ullrich Roland T.,Holstein Arne,Dietlein Markus,Wolf Jürgen,Kobe Carsten

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference25 articles.

1. Global cancer statistics

2. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

3. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

4. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

5. Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and 18F-FDG Metabolic Activity in Non-Small Cell Lung Cancer;Frontiers in Oncology;2022-04-20

2. New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies;Annals of Nuclear Medicine;2022-01-14

3. Molecular Imaging Precision Medicine;Advances in Imaging;2022

4. Update on Molecular Imaging and Precision Medicine in Lung Cancer;Radiologic Clinics of North America;2021-09

5. “PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”;Seminars in Nuclear Medicine;2021-09